Celldex Therapeutics, Inc.
Anti-ALK Antibodies and Methods for Use Thereof
Last updated:
Abstract:
Provided herein are compositions, methods and uses involving antibodies that specifically bind to ALK, a receptor tyrosine kinase, and modulate the expression and/or activity of ALK. Also provided are uses and methods for treating, e.g., managing, disorders, such as cancer.
Status:
Application
Type:
Utility
Filling date:
26 Aug 2016
Issue date:
21 May 2020